Information
-
Trademark
-
85926577
-
Serial Number
85926577
-
Registration Number
4480276
-
International Classifications
-
Filing Date
May 08, 2013
11 years ago
-
Registration Date
February 11, 2014
10 years ago
-
Transaction Date
February 27, 2024
10 months ago
-
Status Date
January 24, 2024
11 months ago
-
Published for Opposition Date
November 26, 2013
11 years ago
-
Renewal Date
February 11, 2024
11 months ago
-
Location Date
January 24, 2024
11 months ago
-
Status Code
800
-
Current Location
GENERIC WEB UPDATE
Employee Name
HWANG, JOHN C B
-
Attorney Docket Number
0013048C
Attorney Name
M. Scott Alprin
Law Office Assigned Location Code
M50
-
Owners
Mark Drawing Code
3000
Mark Identification
V VETTER
Case File Statements
- DM0000: The mark consists of a letter "V" with a circle above the letter and the term "VETTER" below the letter. A horizontal line is above "VETTER" and below the "V" and is intersected by the bottom point of the letter "V".
- GS0071: [ Machine tools, motors, couplings and clutches, drive belts, filling machines, labeling machines packaging machines, box-making machines ALL for erecting, filling and closing of cardboard and foldable boxes; machines for washing, filling and closing medical syringes and vials; INDUSTRIAL robots; mechanical transport machines for the transfer of containers between processing stations, and thermoforming machines for producing, filling and sealing of blister packaging; and machines for controlling the supply and filling of goods in containers ]
- GS0051: [ Pharmaceutical preparations and medicaments, solutions for oral use, sterile solutions and solutions for injections all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, kidney disease, intestinal disorder, lung and bronchial disorder, liver dysfunction, oral and laryngeal disease, optical and cranial disorders; pharmaceutical preparations containing heparins, vaccines, calcitonins, prostaglandins, anaesthestics, reconstruction diluents, human growth hormone, monoclonal antibodies, epo, urokinase, factor VIII, gnrh analogs, and recombinant proteins eye drops, solutions for contact lenses all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, kidney disease, intestinal disorder, lung and bronchial disorder, liver dysfunction, oral and laryngeal disease, optical and cranial disorders; fillings of liquid, semi-solid or solid substances, namely, pharmaceutical preparations in solvated form as solutions with active agents, as powders with solvent or as lyophilistates with solvent in injection systems, namely, in injection syringes and instruments for infections, injectors, injector pens as well as in single chamber, double chamber and disposable syringes, as well as solutions for oral use as well as sterile solutions, solutions for injections including aseptic filling of injection solutions all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, kidney disease, intestinal disorder, lung and bronchial disorder, liver dysfunction, oral and laryngeal disease, optical and cranial disorders; preparations containing heparins, vaccines, calcitonins, prostaglandins, anaesthestics, reconstruction diluents, human growth hormone, monoclonal antibodies, epo, urokinase, factor VIII, gnrh analogs, and recombinant proteins all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, kidney disease, intestinal disorder, lung and bronchial disorder, liver dysfunction, oral and laryngeal disease, optical and cranial disorders; tampons with and without disinfectants and bandages separately or jointly packed, and in sterile packages ]
- CC0000: Color is not claimed as a feature of the mark.
- GS0101: Medical injection systems, namely, syringes and instruments for injections, injectors, injection pens auto-injectors as well as single chamber and double chamber disposable syringes, all sold empty; containers for medicaments made from glass and/or plastics and syringe holders for ready-to-use syringes for picking-up and handling of syringes
- GS0421: Design and development of injection syringes and instruments and injectors and corresponding packages; chemical and microbiological analyses for scientific and forensic research purposes
Case File Event Statements
-
1/24/2024 - 11 months ago
31 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Type: NA89
-
1/24/2024 - 11 months ago
30 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Type: RNL1
-
1/24/2024 - 11 months ago
29 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Type: 89AG
-
1/23/2024 - 11 months ago
28 - TEAS SECTION 8 & 9 RECEIVED
Type: E89R
-
2/11/2023 - a year ago
27 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Type: REM2
-
5/6/2020 - 4 years ago
26 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Type: ASCK
-
4/29/2020 - 4 years ago
25 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Type: ASGN
-
4/3/2020 - 4 years ago
24 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Type: NA85
-
4/3/2020 - 4 years ago
23 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Type: C15P
-
4/2/2020 - 4 years ago
22 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Type: APRE
-
2/7/2020 - 4 years ago
21 - TEAS SECTION 8 & 15 RECEIVED
Type: E815
-
2/11/2019 - 5 years ago
20 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Type: REM1
-
2/11/2014 - 10 years ago
19 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
11/26/2013 - 11 years ago
18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
11/26/2013 - 11 years ago
17 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
11/6/2013 - 11 years ago
16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
10/18/2013 - 11 years ago
15 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
10/17/2013 - 11 years ago
14 - ASSIGNED TO LIE
Type: ALIE
-
10/2/2013 - 11 years ago
13 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
10/2/2013 - 11 years ago
12 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
10/2/2013 - 11 years ago
11 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
10/2/2013 - 11 years ago
10 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
10/2/2013 - 11 years ago
9 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
8/30/2013 - 11 years ago
8 - NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Type: GEAN
-
8/30/2013 - 11 years ago
7 - EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Type: GEAP
-
8/30/2013 - 11 years ago
6 - COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Type: EPEN
-
8/30/2013 - 11 years ago
5 - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Type: CPEA
-
8/26/2013 - 11 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
5/15/2013 - 11 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
5/14/2013 - 11 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
5/11/2013 - 11 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP